ADAPTIMMUNE THERAPEUTICS PLC filings

SEC filings by ADAPTIMMUNE THERAPEUTICS PLC (ownership)
TypeFiledFilerSubjectShares OwnedPercent Owned
SC 13G/A2024-03-26EcoR1 Capital, LLCAdaptimmune Therapeutics PLC164,424,42010.7%EDGAR
SC 13G/A2024-02-14Long Focus Capital Management, LLCAdaptimmune Therapeutics PLC12,086,9155.3%EDGAR
SC 13G/A2024-02-14BAKER BROS. ADVISORS LPAdaptimmune Therapeutics PLC65,815,6924.8%EDGAR
SC 13G2024-01-30EcoR1 Capital, LLCAdaptimmune Therapeutics PLC113,424,4207.7%EDGAR
SC 13G/A2024-01-29BAILLIE GIFFORD & COAdaptimmune Therapeutics PLC95,472,8407.0%EDGAR
SC 13G2023-11-08Long Focus Capital Management, LLCAdaptimmune Therapeutics PLC6,582,7982.9%EDGAR
SC 13G/A2023-07-10Matrix Capital Management Company, LPAdaptimmune Therapeutics PLC233,845,11017.3%EDGAR
SC 13D/A2023-03-30New Enterprise Associates 14, L.P.Adaptimmune Therapeutics PLC102,478,67210.3%EDGAR
SC 13G/A2023-02-14PFM Health Sciences, LPAdaptimmune Therapeutics PLC-3.0%EDGAR
SC 13G/A2023-02-13Capital World InvestorsAdaptimmune Therapeutics PLC00.0%EDGAR
SC 13G/A2023-01-18BAILLIE GIFFORD & COAdaptimmune Therapeutics PLC103,019,63410.5%EDGAR
SC 13G/A2022-12-02BAILLIE GIFFORD & COAdaptimmune Therapeutics PLC102,618,55210.4%EDGAR
SC 13G2022-05-09PFM Health Sciences, LPAdaptimmune Therapeutics PLC-5.8%EDGAR
SC 13G/A2022-01-18BAILLIE GIFFORD & COAdaptimmune Therapeutics PLC82,538,1128.8%EDGAR
SC 13G/A2021-02-16Matrix Capital Management Company, LPAdaptimmune Therapeutics PLC233,845,11025.2%EDGAR
SC 13G2021-02-16BAKER BROS. ADVISORS LPAdaptimmune Therapeutics PLC58,985,2626.4%EDGAR
SC 13G2021-02-16Capital World InvestorsAdaptimmune Therapeutics PLC48,016,2005.2%EDGAR
SC 13G2021-01-28BAILLIE GIFFORD & COAdaptimmune Therapeutics PLC62,146,6806.7%EDGAR
SC 13G/A2020-02-14Matrix Capital Management Company, LPAdaptimmune Therapeutics PLC168,000,00026.6%EDGAR
SC 13G/A2020-02-14Capital World InvestorsAdaptimmune Therapeutics PLC40,756,2006.4%EDGAR